We are live on ! Find out more
BNP Paribas Asset Management

BNP Paribas Asset Management Portfolio holdings

AUM $86.1B
1-Year Est. Return 29.11%
This Fund
S&P 500
This Quarter Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
Cap. Flow
+$4.86B
Cap. Flow %
5.64%
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$1.43B
2
TTE icon
TotalEnergies
TTE
+$626M
3
DB icon
Deutsche Bank
DB
+$326M
4
STLA icon
Stellantis
STLA
+$263M
5
AVGO icon
Broadcom
AVGO
+$237M

Top Sells

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$291M
2
AAPL icon
Apple
AAPL
+$262M
3
AMZN icon
Amazon
AMZN
+$219M
4
TSLA icon
Tesla
TSLA
+$205M
5
META icon
Meta Platforms (Facebook)
META
+$197M

Sector Composition

Rank Sector Weight
1 Technology 35.22%
2 Healthcare 13.97%
3 Financials 10.51%
4 Consumer Discretionary 10.09%
5 Industrials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MVST icon
2176
Microvast
MVST
$287M
$7.17K ﹤0.01%
4,783
-22,455
-82% -$54.1K
FUBO icon
2177
FuboTV Inc
FUBO
$254M
$6.71K ﹤0.01%
709
+323
+84% +$6.4K
ALIT icon
2178
Alight
ALIT
$482M
$5.14K ﹤0.01%
441
+137
+45% +$3.27K
REVB icon
2179
Revelation Biosciences
REVB
$4.18M
$11 ﹤0.01%
9
-1
-10% -$2
AIV
2180
Aimco
AIV
$380M
– –
-1,736
Closed -$10K
AKBA icon
2181
Akebia Therapeutics
AKBA
$327M
– –
-4,249
Closed -$7K
ALEX
2182
DELISTED
Alexander & Baldwin
ALEX
– –
-8,918
Closed -$185K
ASND icon
2183
Ascendis Pharma A/S
ASND
$16.6B
– –
-72,106
Closed -$15.4M
AVXL icon
2184
Anavex Life Sciences
AVXL
$230M
– –
-1,321
Closed -$5K
BCYC
2185
Bicycle Therapeutics
BCYC
$290M
– –
-568,225
Closed -$4.02M
BKH icon
2186
Black Hills Corp
BKH
$5.72B
– –
-2,309
Closed -$160K
BRSP
2187
BrightSpire Capital
BRSP
$679M
– –
-1,473
Closed -$8K
BV icon
2188
BrightView Holdings
BV
$1.32B
– –
-688
Closed -$9K
CABO icon
2189
Cable One
CABO
$211M
– –
-8,217
Closed -$927K
CADE
2190
DELISTED
Cadence Bank
CADE
– –
-2,838
Closed -$122K
CDTX
2191
DELISTED
Cidara Therapeutics
CDTX
– –
-22,538
Closed -$4.98M
CFLT
2192
DELISTED
Confluent
CFLT
– –
-4,045
Closed -$122K
CMA
2193
DELISTED
Comerica
CMA
– –
-1,883
Closed -$164K
CNNE icon
2194
Cannae Holdings
CNNE
$631M
– –
-8,032
Closed -$126K
CNS icon
2195
Cohen & Steers
CNS
$4.11B
– –
-132
Closed -$8K
CODI icon
2196
Compass Diversified
CODI
$746M
– –
-1,430
Closed -$7K
CSWC icon
2197
Capital Southwest
CSWC
$1.46B
– –
-3,677
Closed -$81K
CTOS icon
2198
Custom Truck One Source
CTOS
$2.47B
– –
-1,314
Closed -$8K
CYBR
2199
DELISTED
CyberArk
CYBR
– –
-33,917
Closed -$15.1M
DH icon
2200
Definitive Healthcare
DH
$72.4M
– –
-34,934
Closed -$100K
86 87
88
89 90

Similar funds

Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BNP Paribas Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.

  • BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
  • BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
  • BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
  • BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
  • BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
  • BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
  • BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.